Picture of Co-Diagnostics logo

CODX — Co-Diagnostics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Diagnostics Inc expected to post a loss of 21 cents a share - Earnings Preview

* Co-Diagnostics Inc  CODX.OQ   CODX.O  is expected to show
a rise
in quarterly revenue when it reports  results on May 9 for the
period ending March 31 2024
    * The Salt Lake City Utah-based  company is expected to
report a
407.5% increase in revenue to $3.05 million from $601 thousand a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Co-Diagnostics Inc is
for a
loss of 21 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
Co-Diagnostics
Inc is $2.50​, above​ its last closing price of $1.26. ​​​

This summary was machine generated May 8 at 02:22 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Co-Diagnostics

See all news